Sector portfolio · Private equity · United States

RA Capital Management's Pharma portfolio

RA Capital Management has backed 44 Pharma startups in rounds we track, $8.1B between them, shown by the stage each has reached. The best-funded is Mineralys Therapeutics.

44startups backed
4stages
$8.1Braised between them
Stage not reportedbiggest stage

RA Capital Management's whole portfolioRA Capital Management's profile

Stage not reported

21

Series B

10

Series C and later

7

Series A

6

Segment by segment

Stage not reported

21 startups · $4.3B raised

  1. Mineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.United States$788M
  2. Dianthus TherapeuticsDianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.United States$719M
  3. VaxcyteVaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.United States$633M
  4. GH ResearchGH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.Ireland$268M
  5. IInhibrxUnited States$265M
  6. Aurinia PharmaceuticalsAurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.Canada$255M
  7. Edgewise TherapeuticsEdgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.United States$200M
  8. Jade BiosciencesJade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.United States$195M

Series B

10 startups · $1.5B raised

  1. Ollin BiosciencesOllin Biosciences is a clinical-stage biopharmaceutical company based in Austin, Texas, founded in 2023.United States$430M
  2. MetseraMetsera operates as a clinical-stage biopharmaceutical company.United States$215M
  3. KalVista PharmaceuticalsKalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.United States$125M
  4. Diagonal TherapeuticsDiagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe genUnited States$125M
  5. Claris BiotherapeuticsClaris Biotherapeutics is a late-clinical stage biotechnology company based in Jersey City, New Jersey.United States$124M
  6. Triana BiomedicinesTRIANA Biomedicines is a private biopharmaceutical company founded in 2019 and based in Lexington, Massachusetts.United States$120M
  7. CurevoCurevo is a clinical-stage biotech firm that focuses on producing vaccines.United States$110M
  8. Clementia PharmaceuticalsClementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.Canada$93M

Series C and later

7 startups · $1.1B raised

  1. Parabilis MedicinesParabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.United States$380M
  2. Ovid TherapeuticsOvid Therapeutic's purpose is to solve intractable medical problems.United States$166M
  3. Artios PharmaArtios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.United Kingdom$148M
  4. Angitia BiopharmaceuticalsAngitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, dedicated to developing innovative therapiesUnited States$130M
  5. Cyteir TherapeuticsCyteir is developing the next generation of synthetic lethal therapies to treat cancer.United States$126M
  6. Be BiopharmaBe Biopharma, also known as Be Bio, is a clinical-stage biotechnology company based in Cambridge, Massachusetts.United States$92M
  7. GametoGameto is a biotechnology company founded in 2020, dedicated to advancing women’s reproductive health.United States$44M

Series A

6 startups · $1.2B raised

  1. Korsana BiosciencesKorsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.United States$530M
  2. ABAiolos BioAiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.United States$245M
  3. Solstice OncologySolstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.United States$225M
  4. Stipple BioStipple Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2022.United States$100M
  5. Rampart BioscienceRampart Bioscience is a private biotechnology company focused on developing non-viral, DNA-based gene medicines for genetically drUnited States$85M
  6. Typewriter TherapeuticsTypewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.United States$56M

How this map is made. Every startup here works in Pharma and has raised money in a round we track that names RA Capital Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioRA Capital Management's Healthtech portfolio10 startups · $1.2BPortfolio mapRA Capital Management portfolio map264 startups · $48BCo-investorsWho invests with RA Capital Management152 co-investorsSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8B

Raising from investors like RA Capital Management?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps